Verastem reported $831K in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
AbbVie USD 59M 13M Dec/2025
AstraZeneca USD 73M 62M Mar/2026
Curis USD 806K 9K Sep/2023
Cytokinetics USD 11.02M 448K Mar/2026
Gilead Sciences USD 95M 7M Dec/2025
Incyte USD 33.69M 2.93M Mar/2026
Pfizer USD 115M 51M Mar/2026
Verastem USD 831K 1.04M Sep/2024